Metraipolis › archive › dc_65485d97367d
Efficacy and Safety of IL-4Rα and IL-5/IL-5R Targeted Biologic Therapies in Type 2 Inflammatory Airway Diseases: A Systematic Review and Meta-Analysis — Europe PMC PMID:42452466
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42452466
- DOI
- 10.3390/jcm15135004
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T16:54:00.295Z
- SHA-256 of the archived text
0873d49fe128d717cf3eab4468c4b94e907ed0cbebf759786d8845059fe5ddb4- Stable URL of this page
https://metraipolis.com/documento/dc_65485d97367d
How to cite
Efficacy and Safety of IL-4Rα and IL-5/IL-5R Targeted Biologic Therapies in Type 2 Inflammatory Airway Diseases: A Systematic Review and Meta-Analysis — Europe PMC PMID:42452466 — Europe PMC (en), https://europepmc.org/article/MED/42452466 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_65485d97367d (Metraipolis archive dc_65485d97367d, sha256 0873d49fe128d717cf3eab4468c4b94e907ed0cbebf759786d8845059fe5ddb4)
BibTeX
@misc{dc65485d97367d,
title = {Efficacy and Safety of IL-4Rα and IL-5/IL-5R Targeted Biologic Therapies in Type 2 Inflammatory Airway Diseases: A Systematic Review and Meta-Analysis — Europe PMC PMID:42452466},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42452466},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_65485d97367d; sha256 0873d49fe128d717cf3eab4468c4b94e907ed0cbebf759786d8845059fe5ddb4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42452466. Agents can read the archived copy with the MCP tool read_document.